TONIX PHARMACEUTICALS HOLDING CORP. (NASDAQ:TNXP) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersItem 5.02
(b) On September 5, 2018, Ernest Mario, PhD, age 80, notified the Board of Directors (the “Board”) of Tonix Pharmaceuticals Holding Corp. (the “Company”) that he was resigning from the Board effective September 5, 2018. Dr. Mario was a member of the Compensation Committee. Dr. Mario did not resign from the Board due to any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.
(d) Also on September 5, 2018, the Board, on the recommendation of its Nominating and Corporate Governance Committee (the “NCG Committee”), appointed Adeoye Olukotun, M.D., as director of the Company, effective immediately.
Dr. Olukotun, age 67, has been the Chief Executive Officer of CR Strategies, LLC, a medical products consulting company, since 2000, and was the Chief Executive Officer of EpiGen Pharmaceuticals, Inc., a pharmaceutical company, from 2014 to January of 2018. Dr. Olukotun served as Vice Chairman of CardoVax, Inc., a pharmaceutical company, from 2012 to 2016, and as its Chief Executive Officer from 2006 to 2012. He is also co-founder of VIA Pharmaceuticals, Inc., a pharmaceutical company, and served as the company’s Chief Medical Officer from 2004 to 2008.
The Board awarded Dr. Olukotun 15,000 stock options, which vest on the Company’s 2019 annual meeting of shareholders and are exercisable at $1.03 per share.
There are no arrangements or understandings to which Dr. Olukotun was appointed as a director, and there are no related party transactions between the Company and Dr. Olukotun reportable under Item 404(a) of Regulation S-K.
| Item 7.01 | Regulation FD Disclosure. |
A copy of the press release announcing Dr. Olukotun’s appointment to the Board and Dr. Mario’s resignation is furnished as Exhibit 99.01.
| Item 9.01 | Financial Statements and Exhibits. |
Tonix Pharmaceuticals Holding Corp. ExhibitEX-99.01 2 s112607_ex99-01.htm EXHIBIT 99.01 Exhibit 99.01 Tonix Pharmaceuticals Announces New Board Member,…To view the full exhibit click here
